-
1
-
-
33750603100
-
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
-
Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4539-4544
-
-
Govindan, R.1
Page, N.2
Morgensztern, D.3
-
2
-
-
26644438582
-
Small-cell lung cancer
-
Jackman D.M., Johnson B.E. Small-cell lung cancer. Lancet 2005, 366:1385-1396.
-
(2005)
Lancet
, vol.366
, pp. 1385-1396
-
-
Jackman, D.M.1
Johnson, B.E.2
-
4
-
-
0027064913
-
Meta-analysis: state of the science
-
Dickerson K., Berlin J.A. Meta-analysis: state of the science. Epidemiol Rev 1992, 14:154-176.
-
(1992)
Epidemiol Rev
, vol.14
, pp. 154-176
-
-
Dickerson, K.1
Berlin, J.A.2
-
5
-
-
33244455415
-
Traitements en oncologie thoracique: l'apport des meta-analyses
-
8S81-9
-
Sculier J.P. Traitements en oncologie thoracique: l'apport des meta-analyses. Rev Mal Respir 2005, 22. 8S81-9.
-
(2005)
Rev Mal Respir
, vol.22
-
-
Sculier, J.P.1
-
6
-
-
5444269445
-
Meta-analyses based on abstracted data: a step in the right direction, but only a first step
-
Piedbois P., Buyse M. Meta-analyses based on abstracted data: a step in the right direction, but only a first step. J Clin Oncol 2004, 22:3839-3841.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3839-3841
-
-
Piedbois, P.1
Buyse, M.2
-
8
-
-
84876997473
-
-
Lung cancer, oat cell (small cell). <> [accessed June 10, 2012].
-
Maghfoor I, Perry M. Lung cancer, oat cell (small cell). <> [accessed June 10, 2012]. http://emedicine.medscape.com/article/280104-overview.
-
-
-
Maghfoor, I.1
Perry, M.2
-
9
-
-
0034129381
-
Is there a case for cisplatin in the treatment of small-cell lung cancer A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
-
Pujol J.L., Carestia L., Daurès J.P. Is there a case for cisplatin in the treatment of small-cell lung cancer A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000, 83:8-15.
-
(2000)
Br J Cancer
, vol.83
, pp. 8-15
-
-
Pujol, J.L.1
Carestia, L.2
Daurès, J.P.3
-
10
-
-
55049126744
-
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
-
Amarasena I.U., Walters J.A., Wood-Baker R., Fong K. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev 2008, 8(4):CD006849.
-
(2008)
Cochrane Database Syst Rev
, vol.8
, Issue.4
-
-
Amarasena, I.U.1
Walters, J.A.2
Wood-Baker, R.3
Fong, K.4
-
11
-
-
34848884868
-
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed
-
Simon G.R., Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed. Chest 2007, 132:324S-339S.
-
(2007)
Chest
, vol.132
-
-
Simon, G.R.1
Turrisi, A.2
-
12
-
-
84876996439
-
-
National Cancer Comprehensive Center - Clinical Practice Guidelines in Oncology - Small cell Lung Cancer. Version v2.2012. <> [accessed June 10, 2012].
-
National Cancer Comprehensive Center - Clinical Practice Guidelines in Oncology - Small cell Lung Cancer. Version v2.2012. <> [accessed June 10, 2012]. http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf.
-
-
-
-
13
-
-
77954347979
-
Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
Sorensen M., Pijls-Joannesma M., Felip E. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl. 5):120-125.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
, pp. 120-125
-
-
Sorensen, M.1
Pijls-Joannesma, M.2
Felip, E.3
-
14
-
-
76749130508
-
Cisplatin versus carboplatin-based regimens in the treatment of small cell lung cancer (SCLC): meta-analysis of published randomized clinical trials (RCTs)
-
abstr D6.3
-
Rossi A., Di Maio M., Martelli O., Garassino M.C., Maione P., Gridelli C. Cisplatin versus carboplatin-based regimens in the treatment of small cell lung cancer (SCLC): meta-analysis of published randomized clinical trials (RCTs). J Thorac Oncol 2009, 4(Suppl. 1):S397-S398. abstr D6.3.
-
(2009)
J Thorac Oncol
, vol.4
, Issue.SUPPL. 1
-
-
Rossi, A.1
Di Maio, M.2
Martelli, O.3
Garassino, M.C.4
Maione, P.5
Gridelli, C.6
-
15
-
-
84863752868
-
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
-
Rossi A., Di Maio M., Chiodini P., et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012, 30:1692-1698.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1692-1698
-
-
Rossi, A.1
Di Maio, M.2
Chiodini, P.3
-
16
-
-
0033797356
-
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
-
Mascaux C., Paesmans M., Berghmans T., et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000, 30:23-36.
-
(2000)
Lung Cancer
, vol.30
, pp. 23-36
-
-
Mascaux, C.1
Paesmans, M.2
Berghmans, T.3
-
17
-
-
35348996153
-
Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis
-
Jiang L., Yang K.H., Mi D., et al. Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis. Clin Lung Cancer 2007, 8:497-501.
-
(2007)
Clin Lung Cancer
, vol.8
, pp. 497-501
-
-
Jiang, L.1
Yang, K.H.2
Mi, D.3
-
18
-
-
77953149371
-
A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
-
Jiang J., Liang X., Zhou X., et al. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2010, 5:867-873.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 867-873
-
-
Jiang, J.1
Liang, X.2
Zhou, X.3
-
19
-
-
78650513543
-
Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis
-
Lima J.P., dos Santos L.V., Sasse E.C., Lima C.S., Sasse A.D. Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 2010, 5:1986-1993.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1986-1993
-
-
Lima, J.P.1
dos Santos, L.V.2
Sasse, E.C.3
Lima, C.S.4
Sasse, A.D.5
-
20
-
-
79551560232
-
Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy
-
Guo S., Liang Y., Zhou Q. Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy. J Thorac Oncol 2011, 6:406-408.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 406-408
-
-
Guo, S.1
Liang, Y.2
Zhou, Q.3
-
21
-
-
84876954506
-
Meta-analysis of published randomized clinical trials (RCTs) comparing platinum/etoposide (PE) versus platinum/topoisomerase 1 inhibitors (PTIs) regimens for extensive-disease small-cell lung cancer (ED-SCLC)
-
abstr 447P
-
Cinquini M., Martelli O., Rossi A., Piva S., Farina G., Torri V. Meta-analysis of published randomized clinical trials (RCTs) comparing platinum/etoposide (PE) versus platinum/topoisomerase 1 inhibitors (PTIs) regimens for extensive-disease small-cell lung cancer (ED-SCLC). Ann Oncol 2010, 21(Suppl. 8):viii150. abstr 447P.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 8
, pp. 8150
-
-
Cinquini, M.1
Martelli, O.2
Rossi, A.3
Piva, S.4
Farina, G.5
Torri, V.6
-
22
-
-
84858322703
-
An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
-
Shao N., Jin S., Zhu W. An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2012, 7:470-472.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 470-472
-
-
Shao, N.1
Jin, S.2
Zhu, W.3
-
23
-
-
0037050354
-
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer
-
Noda K., Nishiwaki Y., Kawahara M., et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer. N Engl J Med 2002, 346:85-91.
-
(2002)
N Engl J Med
, vol.346
, pp. 85-91
-
-
Noda, K.1
Nishiwaki, Y.2
Kawahara, M.3
-
24
-
-
33646447066
-
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
-
Hanna N., Bunn P.A., Langer C., et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006, 24:2038-2043.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2038-2043
-
-
Hanna, N.1
Bunn, P.A.2
Langer, C.3
-
25
-
-
66349102227
-
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
-
Lara P.N., Natale R., Crowley J., et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009, 27:2530-2535.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2530-2535
-
-
Lara, P.N.1
Natale, R.2
Crowley, J.3
-
26
-
-
0026716516
-
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung A meta-analysis
-
Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung A meta-analysis. J Clin Oncol 1992, 10:890-895.
-
(1992)
J Clin Oncol
, vol.10
, pp. 890-895
-
-
Warde, P.1
Payne, D.2
-
27
-
-
0026482388
-
A meta-analysis of thoracic radiotherapy for small-cell lung cancer
-
Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992, 327:1618-1624.
-
(1992)
N Engl J Med
, vol.327
, pp. 1618-1624
-
-
Pignon, J.P.1
Arriagada, R.2
Ihde, D.C.3
-
28
-
-
16244389133
-
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
-
Fried D.B., Morris D.E., Poole C., et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004, 22:4837-4845.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4837-4845
-
-
Fried, D.B.1
Morris, D.E.2
Poole, C.3
-
29
-
-
9244240966
-
A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer
-
Huncharek M., McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist 2004, 9:665-672.
-
(2004)
Oncologist
, vol.9
, pp. 665-672
-
-
Huncharek, M.1
McGarry, R.2
-
30
-
-
33645304581
-
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
-
De Ruysscher D., Pijls-Johannesma M., Vansteenkiste J., Kester A., Rutten I., Lambin P. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 2006, 17:543-552.
-
(2006)
Ann Oncol
, vol.17
, pp. 543-552
-
-
De Ruysscher, D.1
Pijls-Johannesma, M.2
Vansteenkiste, J.3
Kester, A.4
Rutten, I.5
Lambin, P.6
-
31
-
-
33644991074
-
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
-
De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006, 24:1057-1063.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1057-1063
-
-
De Ruysscher, D.1
Pijls-Johannesma, M.2
Bentzen, S.M.3
-
32
-
-
84876969084
-
A meta-analysis of randomised trials using individual patient data on the timing of chest radiotherapy in patients with limited stage small cell lung cancer
-
abstr MO19.03
-
De Ruysscher D., Paris E., Le Pechoux C., et al. A meta-analysis of randomised trials using individual patient data on the timing of chest radiotherapy in patients with limited stage small cell lung cancer. J Thorac Oncol 2011, 6(Suppl. 2):S641-S642. abstr MO19.03.
-
(2011)
J Thorac Oncol
, vol.6
, Issue.SUPPL. 2
-
-
De Ruysscher, D.1
Paris, E.2
Le Pechoux, C.3
-
33
-
-
0345062339
-
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
-
Aupérin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999, 341:476-484.
-
(1999)
N Engl J Med
, vol.341
, pp. 476-484
-
-
Aupérin, A.1
Arriagada, R.2
Pignon, J.P.3
-
34
-
-
3042759877
-
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
-
Meert A.P., Paesmans M., Berghmans T., et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001, 1:5.
-
(2001)
BMC Cancer
, vol.1
, pp. 5
-
-
Meert, A.P.1
Paesmans, M.2
Berghmans, T.3
-
35
-
-
34547937885
-
Prophylactic cranial irradiation in extensive small-cell lung cancer
-
EORTC Radiation Oncology Group and Lung Cancer Group
-
Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664-672. EORTC Radiation Oncology Group and Lung Cancer Group.
-
(2007)
N Engl J Med
, vol.357
, pp. 664-672
-
-
Slotman, B.1
Faivre-Finn, C.2
Kramer, G.3
-
36
-
-
29144480913
-
Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC). A metaanalysis of the published controlled trials
-
Bozcuk H., Artac M., Ozdogan M., Savas B. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC). A metaanalysis of the published controlled trials. Cancer 2005, 104:2650-2657.
-
(2005)
Cancer
, vol.104
, pp. 2650-2657
-
-
Bozcuk, H.1
Artac, M.2
Ozdogan, M.3
Savas, B.4
-
37
-
-
77957020019
-
Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis
-
Rossi A., Garassino M.C., Cinquini M., et al. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2010, 70:119-128.
-
(2010)
Lung Cancer
, vol.70
, pp. 119-128
-
-
Rossi, A.1
Garassino, M.C.2
Cinquini, M.3
-
38
-
-
67449124671
-
Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature
-
Jiang J., Shi H.Z., Deng J.M., Liang Q.L., Qin S.M., Wu C. Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature. Lung Cancer 2009, 65:214-218.
-
(2009)
Lung Cancer
, vol.65
, pp. 214-218
-
-
Jiang, J.1
Shi, H.Z.2
Deng, J.M.3
Liang, Q.L.4
Qin, S.M.5
Wu, C.6
-
39
-
-
0029894306
-
G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation
-
Messori A., Trippoli S., Tendi E. G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation. J Clin Pharm Ther 1996, 21:57-63.
-
(1996)
J Clin Pharm Ther
, vol.21
, pp. 57-63
-
-
Messori, A.1
Trippoli, S.2
Tendi, E.3
-
40
-
-
0036021711
-
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis
-
Berghmans T., Paesmans M., Lafitte J.J., Mascaux C., Meert A.P., Sculier J.P. Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer 2002, 37:115-123.
-
(2002)
Lung Cancer
, vol.37
, pp. 115-123
-
-
Berghmans, T.1
Paesmans, M.2
Lafitte, J.J.3
Mascaux, C.4
Meert, A.P.5
Sculier, J.P.6
-
41
-
-
0023677771
-
Teniposide in the treatment of small cell lung cancer: the influence of prior chemotherapy
-
Giaccone G., Donadio M., Bonardi G., Testori F., Calciati A. Teniposide in the treatment of small cell lung cancer: the influence of prior chemotherapy. J Clin Oncol 1988, 6:1264-1270.
-
(1988)
J Clin Oncol
, vol.6
, pp. 1264-1270
-
-
Giaccone, G.1
Donadio, M.2
Bonardi, G.3
Testori, F.4
Calciati, A.5
-
42
-
-
0031157599
-
Second-line chemotherapy for relapsed small cell lung cancer
-
Ebi N., Kubota K., Nishiwaki Y., et al. Second-line chemotherapy for relapsed small cell lung cancer. Jpn J Clin Oncol 1997, 27:166-169.
-
(1997)
Jpn J Clin Oncol
, vol.27
, pp. 166-169
-
-
Ebi, N.1
Kubota, K.2
Nishiwaki, Y.3
-
43
-
-
33645799480
-
Small cell lung cancer
-
Rosti G., Bevilacqua G., Bidoli P., Portalone L., Santo A., Genestreti G. Small cell lung cancer. Ann Oncol 2006, 17(Suppl. 2):5-10.
-
(2006)
Ann Oncol
, vol.17
, Issue.SUPPL. 2
, pp. 5-10
-
-
Rosti, G.1
Bevilacqua, G.2
Bidoli, P.3
Portalone, L.4
Santo, A.5
Genestreti, G.6
-
44
-
-
34247850949
-
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline
-
Cheng S., Evans W.K., Stys-Norman D., et al. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 2007, 2:348-354.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 348-354
-
-
Cheng, S.1
Evans, W.K.2
Stys-Norman, D.3
-
45
-
-
77951461144
-
The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
-
Loveman E., Jones J., Hartwell D., et al. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Health Technol Assess 2010, 14:1-204.
-
(2010)
Health Technol Assess
, vol.14
, pp. 1-204
-
-
Loveman, E.1
Jones, J.2
Hartwell, D.3
-
46
-
-
77955532240
-
Systematic review of topotecan (Hycamtin) in relapsed small cell lung cancer
-
Riemsma R., Simons J.P., Bashir Z., Gooch C.L., Kleijnen J. Systematic review of topotecan (Hycamtin) in relapsed small cell lung cancer. BMC Cancer 2010, 10:436.
-
(2010)
BMC Cancer
, vol.10
, pp. 436
-
-
Riemsma, R.1
Simons, J.P.2
Bashir, Z.3
Gooch, C.L.4
Kleijnen, J.5
-
47
-
-
79151482317
-
Second-line chemotherapy for small-cell lung cancer (SCLC)
-
Kim Y.H., Mishima M. Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev 2011, 37:143-150.
-
(2011)
Cancer Treat Rev
, vol.37
, pp. 143-150
-
-
Kim, Y.H.1
Mishima, M.2
|